000 | 01987 a2200601 4500 | ||
---|---|---|---|
005 | 20250514025446.0 | ||
264 | 0 | _c20020404 | |
008 | 200204s 0 0 eng d | ||
022 | _a1526-8209 | ||
024 | 7 |
_a10.3816/CBC.2001.n.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aReece, D E | |
245 | 0 | 0 |
_aInterim analysis of the use of the anti-idiotype breast cancer vaccine 11D10 (TriAb) in conjunction with autologous stem cell transplantation in patients with metastatic breast cancer. _h[electronic resource] |
260 |
_bClinical breast cancer _cApr 2001 |
||
300 |
_a52-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _ximmunology |
650 | 0 | 4 | _aAntibodies, Monoclonal |
650 | 0 | 4 |
_aBreast Neoplasms _ximmunology |
650 | 0 | 4 |
_aCancer Vaccines _xtherapeutic use |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGlycolipids _ximmunology |
650 | 0 | 4 |
_aGlycoproteins _ximmunology |
650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunity, Cellular |
650 | 0 | 4 | _aLipid Droplets |
650 | 0 | 4 | _aLymphocyte Activation |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
650 | 0 | 4 | _aTransplantation, Autologous |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aFoon, K A | |
700 | 1 | _aBattacharya-Chatterjee, M | |
700 | 1 | _aAdkins, D | |
700 | 1 | _aBroun, E R | |
700 | 1 | _aConnaghan, D G | |
700 | 1 | _aDipersio, J F | |
700 | 1 | _aHolland, H K | |
700 | 1 | _aHoward, D S | |
700 | 1 | _aHale, G A | |
700 | 1 | _aKlingemann, H G | |
700 | 1 | _aMunn, R K | |
700 | 1 | _aRaptis, A | |
700 | 1 | _aPhillips, G L | |
773 | 0 |
_tClinical breast cancer _gvol. 2 _gno. 1 _gp. 52-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3816/CBC.2001.n.011 _zAvailable from publisher's website |
999 |
_c11805392 _d11805392 |